TITLE

Discontinuation of Secondary Prophylaxis in Patients with Cytomegalovirus Retinitis Who Have Responded to Highly Active Antiretroviral Therapy

AUTHOR(S)
Berenguer, Juan; Gonz á lez, Juan; Pulido, Federico; Padilla, Bel é n; Casado, Jos é Luis; Rubio, Rafael; Arribas, Jos é Rarm ó n
PUB. DATE
February 2002
SOURCE
Clinical Infectious Diseases;2/1/2002, Vol. 34 Issue 3, p394
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
We performed a prospective study of discontinuation of sec-ondary prophylaxis against cytomegalovirus (CMV) in 36 patients with acquired immunodeficiency syndrome and qui-escent CMV retinitis after successful treatment with highly active antiretroviral therapy (HAART). No reactivation or progression of retinitis was observed in 35 patients with per-sistent response to HAART, findings that support the dis-continuation of secondary prophylaxis against CMV retinitis in such patients.
ACCESSION #
5860720

 

Related Articles

  • Failure of a prospective trial to detect cytomegalovirus retinitis after initiation of highly... Uphold, Constance R.; Smith, Fran // AIDS Patient Care & STDs;Dec98, Vol. 12 Issue 12, p907 

    Determines the incidence of cytomegalovirus (CMV) retinis prior to and after initiation with highly active antiretroviral therapy (HAART). Decrease in viral loads and increase in CD4+ T-cell counts after starting HAART; Non-occurrence of CMV retinis among patients receiving HAART; Development...

  • HAART PREVENTS CVM PROGRESSION.  // AIDS Patient Care & STDs;Feb2000, Vol. 14 Issue 2, p101 

    Discloses research findings that patients taking highly active antiretroviral therapy (HAART) regimens may be able to stop taking their anti-CMV medications without progression of retinitis. Ability of HAART to rejuvenate the immune system sufficiently enough to control CMV retinitis without...

  • SELF-REPORTED ADHERENCE NOT RELIABLE.  // AIDS Patient Care & STDs;Jan1999, Vol. 13 Issue 1, p59 

    Reports that self-reporting of adherence to various anti-retroviral therapies is not a reliable method when used alone. Electronic monitoring of adherence.

  • Adherence Assessment to Highly Active Antiretroviral Therapy. Tsasis, Peter // AIDS Patient Care & STDs;Mar2001, Vol. 15 Issue 3, p109 

    Adherence to highly active antiretroviral therapy (HAART) is the outcome of a dynamic process of clinical and behavioral interactions. This article reviews factors influencing this process and provides suggestions to enhance adherence to HAART. Interventions to improve adherence to HAART should...

  • Initiation and continuation of newer antiretroviral treatments among medicaid recipients with AIDS. Crystal, Stephen; Sambamoorthi, Usha; Moynihan, Patrick J.; McSpiritt, Elizabeth; Crystal, S; Sambamoorthi, U; Moynihan, P J; McSpiritt, E // JGIM: Journal of General Internal Medicine;Dec2001, Vol. 16 Issue 12, p850 

    Objective: To examine initiation of newer antiretroviral treatments across sociodemographic subgroups during the 3 years following the introduction of these treatments, and explore persistence on treatment and its association with patient characteristics.Design: Merged...

  • Adherence of Human Immunodeficiency Virus-Infected Patients to Antiretroviral Therapy. Singh, Nina; Berman, Stephen M.; Swindells, Susan; Justis, Janice C.; Mohr, Jeffrey A.; Squier, Cheryl; Wagener, Marilyn M. // Clinical Infectious Diseases;10/1/1999, Vol. 29 Issue 4, p824 

    Presents a study which assessed the role of demographic, psychosocial and medical-regimen variables on adherence of HIV-infected patients to antiretroviral therapy. Characteristics of the patients; Data and methods used; Results and discussion.

  • Preface of the Special Issue: "Recent CMV Research". Dufrene, Kayla; DeBiasi, Roberta L.; Colberg-Poley, Anamaris M. // Viruses (1999-4915);Jan2014, Vol. 6 Issue 1, p336 

    A preface to the issue is presented where a congenital cytomegalovirus infection patient discusses her struggles with the disease throughout her life and her willingness to learn more about its symptoms, diagnosis, and treatment.

  • CMV implant more effective than IV therapy.  // AIDS Patient Care & STDs;Dec97, Vol. 11 Issue 6, p458 

    States that sustained-release ganciclovir (Cytovene) intraocular implant (Vitrasert) delays the onset of CMV retinitis in people with acquired immunodeficiency syndrome (AIDS), as compared to standard IV therapy. Data published in `New England Journal of Medicine'; Details on the study; What...

  • Cytomegalovirus encephalitis in an HIV positive patient presenting with a cerebral mass lesion. Bassil, Habib F.; William, Daniel C. // AIDS Patient Care & STDs;Oct97, Vol. 11 Issue 5, p319 

    Presents information on Cytomegalovirus (CMV) and how it occurs as an infection in advance AIDS patients. Information on a patient with right-sided weakness due to CMV; Description of similar cases; Diagnoses of CMV.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics